Hemiasterlin derivatives and uses thereof in the treatment of cancer
Details for Australian Patent Application No. 2003228354 (hide)
International Classifications
Event Publications
14 August 2003 Complete Application Filed
Priority application(s): 60/366,592 22.03.02 US
20 November 2003 Application Open to Public Inspection
Published as AU-B-2003228354
6 December 2007 Assignment before Grant
Eisai Co. Ltd The application has been assigned to Eisai R&D Management Co., Ltd.
11 February 2010 Application Accepted
Published as AU-B-2003228354
4 March 2010 Corrigenda
Applications Accepted - Name Index Under the name Eisai R&D Management Co., Ltd., Application No. 2003228354, under INID (54) correct the co-inventor to read Kowalczyk, James J.
10 June 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser